Menu Search
Equities

Shanghai HeartCare Medical Technology Corp Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6609:HKG.HS

Shanghai HeartCare Medical Technology Corp Ltd

Actions
  • Price (HKD)45.68
  • Today's Change-0.72 / -1.55%
  • Shares traded8.65k
  • 1 Year change+59.16%
  • Beta0.9718
Data delayed at least 15 minutes, as of Feb 16 2026 02:38 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research, development, manufacturing and commercialization of medical device. The Company’s key neuro-interventional products and product candidates include ischemic stroke thrombectomy devices such as Captor thrombectomy stent and aspiration catheter, intracranial stenosis treatment devices such as intracranial balloon dilatation catheter and carotid artery balloon dilatation catheter and embolization protection system, hemorrhagic stroke treatment devices such as vascular reconstruction device and flow diverter device, ischemic stroke prevention devices such as LAA occluder, and vascular access devices such as distal access catheter, microcatheter, balloon guiding catheter, and other devices. The Company mainly conducts its businesses within domestic market.

  • Revenue in HKD (TTM)378.92m
  • Net income in HKD48.01m
  • Incorporated2016
  • Employees327.00
  • Location
    Shanghai HeartCare Medical Technology Corp Ltd1F and 3F, Building 38No. 356, Zhengbo Road, Lingang New AreaPilot Free Trade ZoneSHANGHAI 201201ChinaCHN
  • Phone+86 2 158975055
  • Websitehttps://www.heartcare.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.